SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-052015
Filing Date
2020-09-24
Accepted
2020-09-24 19:27:27
Documents
2
Period of Report
2020-09-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2134
2 POA DOCUMENT poa.txt EX-24.3_938653 2464
  Complete submission text file 0001209191-20-052015.txt   5938
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Issuer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512
Business Address
Levine Alison (Reporting) CIK: 0001825189 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39539 | Film No.: 201196495